Malnutrition Screening Study

January 28, 2026 updated by: Abbott Nutrition

LEVEL-UP Turkish Adult Outpatient Screening Study

This is a non-interventional, cross-sectional, non-randomized, observational study to screen for the risk of malnutrition and sarcopenia in outpatients aged 18 and over who attend hospital clinics for any reason in Turkey.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

7500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Turkey (Türkiye)
    • Konya
      • Meram, Konya, Turkey (Türkiye), 42090
        • Recruiting
        • Necmettin Erbakan University Faculty of Medicine General Surgery

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Participants attending medical and radiation oncology, neurology, and geriatrics outpatient hospital clinics in Turkey

Description

Inclusion Criteria:

  • Participant has voluntarily signed and dated an informed consent form (ICF), approved by an Independent Ethics Committee (IEC)/Institutional Review Board (IRB), and provided other applicable privacy regulation authorization (if applicable) prior to any participation in the study.
  • Participant is ≥ 18 years of age who attend hospital clinics (medical and radiation oncology, neurology, and geriatrics clinics) as an outpatient for any reason.

Exclusion Criteria:

  • NA

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Hospital Clinics
Oncology, Neurology and Geriatric

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Malnutrition Risk
Time Frame: Screening Study Day 1
Measured via R-MAPP Screening Questionnaire completed by participant interview.
Screening Study Day 1
Sarcopenia Risk
Time Frame: Screening Study Day 1
Measured via R-MAPP Screening Questionnaire completed by participant interview.
Screening Study Day 1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body Mass Index (BMI)
Time Frame: Screening Study Day 1
Calculated as weight (kg)/height (m)2
Screening Study Day 1
Calf Circumference
Time Frame: Screening Study Day 1
Measured in cm
Screening Study Day 1
Hand Grip Strength
Time Frame: Screening Study Day 1
Measured in kg by hand grip dynamometer
Screening Study Day 1
Biochemical Parameters
Time Frame: Screening Study Day 1
Albumin, CRP and Vitamin D
Screening Study Day 1
Health Care Utilization
Time Frame: Screening Study Day 1
Number of Outpatient and Hospitalization Admissions during the past 6 months.
Screening Study Day 1
Nutrition Treatment
Time Frame: Screening Study Day 1
Number of participants referred for medical nutrition treatment
Screening Study Day 1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Abbott Nutrition

Investigators

  • Study Chair: Aysugul Alptekin, MD, Abbott Nutrition

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 12, 2026

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

July 1, 2026

Study Registration Dates

First Submitted

November 21, 2025

First Submitted That Met QC Criteria

November 21, 2025

First Posted (Actual)

December 1, 2025

Study Record Updates

Last Update Posted (Actual)

January 29, 2026

Last Update Submitted That Met QC Criteria

January 28, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • DA34

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sarcopenia

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe